Free shipping on orders over $99Ships to the US and Canada New: dosage, calculator and shelf life for all 46 peptides →
BAC WATER IS NOT INCLUDED AND SOLD SEPARATELY

KLOW Peptide Blend - 70mg

(1 customer review)
$95.00
You save

Purpose: Comprehensive investigation into accelerated musculoskeletal healing, systemic inflammation modulation, and complete extracellular matrix repair.

In advanced performance and recovery research, single-compound protocols are often insufficient for addressing severe, multi-system trauma. The KLOW Peptide Blend is a proprietary, research-only formulation engineered to tackle catastrophic tissue damage and chronic inflammation simultaneously.

By combining four of the most heavily researched regenerative peptides—BPC-157, TB-500, KPV, and GHK-Cu—into a single, highly synergistic lyophilized vial, KLOW allows researchers to study rapid, multi-pathway healing. This blend targets everything from severe tendon tears and muscle damage to mucosal inflammation and structural cellular degradation, providing a complete 360-degree regenerative environment.

Bulk Savings

Save Bulk

Quantity Discounts

Quantity3 - 45 - 910 - 1516 +
Price$90.25$85.50$80.75$76.00

Description

KLOW Peptide Blend – 70mg: Multi-Pathway Tissue Repair & Cellular Regeneration

Purpose: Comprehensive investigation into accelerated musculoskeletal healing, systemic inflammation modulation, and complete extracellular matrix repair.

In advanced performance and recovery research, single-compound protocols are often insufficient for addressing severe, multi-system trauma. The KLOW Peptide Blend is a proprietary, research-only formulation engineered to tackle catastrophic tissue damage and chronic inflammation simultaneously.

By combining four of the most heavily researched regenerative peptides—BPC-157, TB-500, KPV, and GHK-Cu—into a single, highly synergistic lyophilized vial, KLOW allows researchers to study rapid, multi-pathway healing. This blend targets everything from severe tendon tears and muscle damage to mucosal inflammation and structural cellular degradation, providing a complete 360-degree regenerative environment.

The Synergy: A Four-Pillar Approach to Regeneration

The true power of the KLOW blend lies in how these four distinct compounds interact, covering every phase of the healing cascade from initial inflammation control to final tissue remodeling.

1. BPC-157 (The Angiogenesis Catalyst)

Body Protection Compound-157 is the foundation of structural repair. It aggressively upregulates vascular endothelial growth factor (VEGF), stimulating the creation of new blood vessels (angiogenesis) directly at the site of injury. This floods damaged tendons, ligaments, and muscle bellies with oxygen and nutrients, drastically accelerating the repair of tissues that typically have poor blood flow.

2. TB-500 (The Cellular Migrator)

While BPC-157 builds the blood supply, TB-500 (a synthetic fraction of Thymosin Beta-4) goes to work on the cellular level. It binds to cellular actin, a protein crucial for cell structure and movement. By upregulating actin, TB-500 allows healing cells to rapidly migrate over long distances through the body to reach and repair damaged muscle tissue, reducing localized scarring and restoring flexibility.

3. KPV (The Inflammatory Modulator)

Before tissue can fully rebuild, aggressive systemic inflammation must be controlled. KPV (Lysine-Proline-Valine) acts as the blend’s internal shield. By penetrating the cell nucleus and inhibiting the NF-κB pathway, KPV shuts down the overactive pro-inflammatory cytokine cascade. This creates a stable, non-hostile biological environment for the other peptides to execute their repair mechanisms.

4. GHK-Cu (The Structural Remodeler)

As the tissue heals, GHK-Cu (Copper Peptide) acts as the final architect. It signals fibroblasts to drastically increase the synthesis of Type I collagen and elastin, ensuring that the newly repaired tissue is mechanically strong and structurally sound. Furthermore, it aids in preventing the disorganized cross-linking of collagen that leads to thick, restrictive scar tissue.

Primary Research Applications

The KLOW Peptide Blend is specifically designed for advanced, in-vitro, and in-vivo modeling where aggressive healing is required:

  • Severe Musculoskeletal Trauma: Simulating the recovery timelines of combined muscle tears, ligament sprains, and joint degradation.

  • Auto-Immune and Inflammatory Response: Studying the suppression of localized and systemic inflammation alongside active tissue regeneration.

  • Post-Surgical Recovery Modeling: Investigating how multi-pathway peptide signaling can accelerate the closure of wounds and restore structural integrity to the extracellular matrix.

Product Specifications & Secure Logistics

Our KLOW blend is synthesized to exact stoichiometric ratios to ensure reliable, reproducible data for your protocols.

  • Format: Lyophilized (freeze-dried) powder sealed in a sterile glass vial.

  • Purity: Verified at >99% via independent High-Performance Liquid Chromatography (HPLC) testing, guaranteeing a clean formulation free from synthesis byproducts.

  • Preparation: Requires reconstitution with Bacteriostatic Water (not included). Must be stored refrigerated (2°C to 8°C) immediately after mixing to preserve the delicate peptide bonds of the four compounds.

Fast, Guaranteed Shipping to Canada & the USA Your research cannot afford logistical delays. We utilize highly secure, tracked shipping networks to deliver the KLOW blend rapidly across the United States and Canada. For Canadian researchers, our domestic shipping completely bypasses the Canada Border Services Agency (CBSA), eliminating the risk of customs seizures. U.S. researchers benefit from priority cross-border logistics, ensuring your vials arrive intact, on time, and ready for study.

Additional information

Country

Canada, USA

1 review for KLOW Peptide Blend – 70mg

  1. Sarah_G –

    Saw way better results for my skin and joints using this blend than trying to mix them myself.

Add a review

Your email address will not be published. Required fields are marked *